hotspot -WSS

hotspot

author：hotspot 2025-09-03 07:48:59 - browse：29993

Babies born by in vitro fertilization — when a woman’s egg is fertilized outside of her body and then implanted back into her uterus — skew more heavily male than babies conceived naturally. A study published Monday in the Proceedings of the National Academy of Sciences sheds light on why that happens.

You’ll want to know:

During normal development, female embryos usually shut down the activity of one of their two X chromosomes to keep gene expression levels the same as in male embryos. But researchers at the China Agricultural University saw that this process often went awry in mouse embryos created by IVF. Those female embryos were defective and didn’t develop properly. Researchers said it might be possible to fix the problem by adding a particular chemical (a derivative of vitamin A) to embryos in the lab dish before they’re implanted.

The background:

More than 5 million people have been born using IVF since it was pioneered in 1978. Skewed sex ratio has been debated for decades; one 2010 study found IVF produced as many as 128 boys born for every 100 girls.

Keep in mind:

The study was carried out on IVF embryos in mice, with naturally conceived mouse embryos as the control group. While mice are a commonly used research subject, findings in rodents don’t always translate directly to the biology of humans.

Also note that IVF births account for just 1 to 2 percent of total births in the United States, so having more males born via fertility treatments is unlikely to affect the gender ratio of babies nationwide. “I don’t think anyone should be worried even if there’s a slight increase in male births in patients undergoing fertility care,” said Dr. Mark Sauer, an obstetrician and gynecologist at Columbia University Medical Center, who was not involved in the study.

The bottom line:

Scientists might have figured out the cause for the skewed sex ratio that shows up in IVF births, but it’s not clear yet whether the strategies they propose to fix the issue will work in practice.

Previous article： How one medical school became remarkably diverse
Next article： Life sciences deals on track to hit lowest point since 2017

hotspot

WSS

The (many) problems with a new study criticizing cancer screening

How to fix cancer clinical trials' diversity problem

Listen: Biogen's potential pivot, & Illumina's next chapter

Humana CEO Bruce Broussard to step down in 2024

Illumina names Agilent executive as new CEO

Massive project maps cells in human brain in unprecedented detail

hotspot

hotspot

You’ll want to know:

The background:

Keep in mind:

The bottom line:

focus

As demand for Covid shots wanes, Moderna seeks its next success

How should state employee insurance handle Wegovy?

The high cost of giving birth even with insurance

How doctors and nurses shape Google's AI

United colonoscopy coverage change 'may cost lives,' doctors say

Takeaways from AdvaMed, the largest medical devices conference

Bright Health sells Medicare Advantage business to Molina

STAT Readout Newsletter: Today in biotech, life science news

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The 10 drugs up first for Medicare price negotiation

focus

How to fix cancer clinical trials' diversity problem

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Stem cell treatment guidelines are released by FDA

Researchers CRISPR chickens in bid to protect them from bird flu

The (many) problems with a new study criticizing cancer screening

Humana CEO Bruce Broussard to step down in 2024

hotspot

hotspot

hotspot

explore